Tetsuya Hamaguchi

3PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 28, 2026
Development of a simplified population pharmacokinetic-pharmacodynamic framework for exposure-informed risk stratification of neutropenia during amrubicin treatment.

|Apr 10, 2025
Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study.

Takao Fujisawa, Yoshiaki Nakamura, Hideaki Bando

|Aug 26, 2024
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018).

Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa

Pageof 1

Frequent Collaborators

2 joint publications

Tadamichi Denda

1 joint publications

Atsuo Takashima

1 joint publications

Junki Mizusawa

1 joint publications

Fumio Nagashima